Sanofi
SNYNF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $114,742 | $113,170 | $112,566 | $109,043 |
| - Cash | $7,441 | $8,710 | $12,736 | $10,098 |
| + Debt | $17,906 | $18,422 | $21,212 | $22,414 |
| Enterprise Value | $125,207 | $122,882 | $121,042 | $121,359 |
| Revenue | $44,286 | $46,444 | $40,304 | $39,175 |
| % Growth | -4.6% | 15.2% | 2.9% | – |
| Gross Profit | $31,081 | $32,208 | $31,694 | $26,920 |
| % Margin | 70.2% | 69.3% | 78.6% | 68.7% |
| EBITDA | $11,033 | $11,076 | $13,510 | $11,251 |
| % Margin | 24.9% | 23.8% | 33.5% | 28.7% |
| Net Income | $5,560 | $5,400 | $8,371 | $6,223 |
| % Margin | 12.6% | 11.6% | 20.8% | 15.9% |
| EPS Diluted | 4.43 | 4.3 | 6.66 | 4.95 |
| % Growth | 3% | -35.4% | 34.5% | – |
| Operating Cash Flow | $9,081 | $10,258 | $10,526 | $10,522 |
| Capital Expenditures | -$3,195 | -$1,619 | -$2,201 | -$2,043 |
| Free Cash Flow | $5,886 | $8,639 | $8,325 | $8,479 |